Acrux is a specialty pharmaceutical company, developing and commercialising a range of patented, patient-preferred healthcare products for global markets, using its innovative technology to administer drugs through the skin. Acrux's product pipeline includes treatments of hormonal deficiencies, pain, central nervous system disorders and a contraceptive. Acrux has also licensed its technology to Eli Lilly for veterinary healthcare products.
Acrux Limited
ASX:ACR ISIN:AU000000ACR3
新聞
###
47,590 公司背景瀏覽
- 本頁瀏覽人次: (過去7日: 19) (過去30日: 98) (自發布以來: 7996)